AMD1
S-adenosylmethionine decarboxylase proenzyme
Also known as: DCAM_HUMAN, SAMDC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P17707
- Gene
- AMD1
- Ensembl
- ENSG00000123505
- Chromosome
- 6
- Canonical length
- 334 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes an important intermediate enzyme in polyamine biosynthesis. The polyamines spermine, spermidine, and putrescine are low-molecular-weight aliphatic amines essential for cellular proliferation and tumor promotion. Multiple alternatively spliced transcript variants have been identified. Pseudogenes of this gene are found on chromosomes 5, 6, 10, X and Y. [provided by RefSeq, Dec 2013]
Canonical amino-acid sequenceUniProt
334 residues, UniProt reviewed canonical sequence.
>P17707|AMD1
1 MEAAHFFEGT EKLLEVWFSR QQPDANQGSG DLRTIPRSEW DILLKDVQCS IISVTKTDKQ
61 EAYVLSESSM FVSKRRFILK TCGTTLLLKA LVPLLKLARD YSGFDSIQSF FYSRKNFMKP
121 SHQGYPHRNF QEEIEFLNAI FPNGAAYCMG RMNSDCWYLY TLDFPESRVI SQPDQTLEIL
181 MSELDPAVMD QFYMKDGVTA KDVTRESGIR DLIPGSVIDA TMFNPCGYSM NGMKSDGTYW
241 TIHITPEPEF SYVSFETNLS QTSYDDLIRK VVEVFKPGKF VTTLFVNQSS KCRTVLASPQ
301 KIEGFKRLDC QSAMFNDYNF VFTSFAKKQQ QQQSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AMD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 190 nTPM
Expression across tissuesHPA
Tissue
- prostate: 190 nTPM
- bone marrow: 85 nTPM
- spinal cord: 59 nTPM
- placenta: 56 nTPM
- esophagus: 53 nTPM
- tonsil: 47 nTPM
Single-cell type
- prostatic glandular cells: 1,121 nCPM
- platelets: 629 nCPM
- megakaryocyte-erythroid progenitors: 547 nCPM
- megakaryocyte progenitors: 422 nCPM
- hematopoietic stem cells: 389 nCPM
- erythrocyte progenitors: 380 nCPM
Immune cell
- neutrophil: 103 nTPM
- basophil: 43 nTPM
- eosinophil: 38 nTPM
- non-classical monocyte: 38 nTPM
- myeloid DC: 32 nTPM
- intermediate monocyte: 29 nTPM
Brain region
- white matter: 107 nTPM
- medulla oblongata: 65 nTPM
- spinal cord: 65 nTPM
- basal ganglia: 62 nTPM
- cerebral cortex: 59 nTPM
- pons: 55 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- -0.48
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- identical protein binding
- adenosylmethionine decarboxylase activity
- putrescine binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- S-adenosylmethionine decarboxylase, eukaryotes
- S-adenosylmethionine decarboxylase, core
- S-adenosylmethionine decarboxylase, conserved site
- S-adenosylmethionine decarboxylase-like
- Adenosylmethionine decarboxylase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AMD1 as an antibody target. Whether an autoantibody or antibody against AMD1 could matter depends on whether native AMD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AMD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AMD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...